Meinian Onehealth issued a profit forecast, expecting a net profit attributable to the parent company of 42 million to 62 million yuan for the first three quarters, a year-on-year increase of 70.51% to 151.7%
Meinian Onehealth expects its net profit attributable to shareholders for the first three quarters of 2025 to be between 42 million yuan and 62 million yuan, a year-on-year increase of 70.51% to 151.70%. The net profit after deducting non-recurring gains and losses is expected to be between 8.5 million yuan and 22 million yuan, a year-on-year increase of 4.35% to 170.09%. The company actively promoted revenue growth and inspection work in the third quarter, maintaining stable overall orders and average transaction value, with an increase in the proportion of contracts signed by key customers and the share of inspections
According to the Zhitong Finance APP, Meinian Onehealth (002044.SZ) disclosed its performance forecast for the first three quarters of 2025. The company expects a net profit attributable to shareholders of the listed company to be between 42 million and 62 million yuan, a year-on-year increase of 70.51% to 151.70%; the net profit after deducting non-recurring gains and losses is expected to be between 8.5 million and 22 million yuan, a year-on-year increase of 4.35% to 170.09%.
The announcement stated that as the third quarter enters the peak season for physical examinations, the company is actively promoting revenue growth and examination work. Overall order signing and average customer price remain stable, with an increase in the proportion of key customer orders and examination share. The company continues to drive the conversion, repurchase, and expansion of group and individual examinations through comprehensive customer journey management
